357 related articles for article (PubMed ID: 34461767)
21. Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study.
Bertaux M; Houillier C; Edeline V; Habert MO; Mokhtari K; Giron A; Bergeret S; Hoang-Xuan K; Cassoux N; Touitou V; Choquet S; Soussain C; Kas A
J Neurooncol; 2020 Jun; 148(2):343-352. PubMed ID: 32405997
[TBL] [Abstract][Full Text] [Related]
22. Enhanced MRI and 18F-FDG PET/CT Findings of Primary Central Nervous System Lymphoma Mimicking Encephalitis.
Ge J; Zuo C; Guan Y; Zhao G
Clin Nucl Med; 2016 Oct; 41(10):e436-8. PubMed ID: 27355853
[TBL] [Abstract][Full Text] [Related]
23. Primary central nervous system lymphoma with lymphomatosis cerebri in an immunocompetent child: MRI and 18F-FDG PET-CT findings.
Jain TK; Sharma P; Suman SK; Faizi NA; Bal C; Kumar R
Rev Esp Med Nucl Imagen Mol; 2013; 32(6):394-6. PubMed ID: 23743243
[TBL] [Abstract][Full Text] [Related]
24. Use of F-18 FDG PET/CT in non-Hodgkin lymphoma with central nervous system involvement.
Cimarelli S; Sebban C; Thiesse P; Sunyach MP; Blay JY; Ghesquières H
Clin Nucl Med; 2011 Jun; 36(6):e45-9. PubMed ID: 21552016
[TBL] [Abstract][Full Text] [Related]
25. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
26. [Usefulness and limitation of FDG-PET in the diagnosis of primary central nervous system lymphoma].
Kawai N; Miyake K; Okada M; Yamamoto Y; Nishiyama Y; Tamiya T
No Shinkei Geka; 2013 Feb; 41(2):117-26. PubMed ID: 23378387
[TBL] [Abstract][Full Text] [Related]
27. Primary Central Nervous System Lymphoma Mimicking Wernicke's Encephalopathy.
Wu L; Jin D; Huang D; Yu S
Neurol India; 2021; 69(3):740-743. PubMed ID: 34169880
[TBL] [Abstract][Full Text] [Related]
28. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
[TBL] [Abstract][Full Text] [Related]
29. High 18F-FDOPA PET Uptake in Primary Central Nervous System Lymphoma.
Salgues B; Kaphan E; Molines E; Brun G; Guedj E
Clin Nucl Med; 2021 Jan; 46(1):e59-e60. PubMed ID: 32956128
[TBL] [Abstract][Full Text] [Related]
30. 18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
Karantanis D; O'eill BP; Subramaniam RM; Witte RJ; Mullan BP; Nathan MA; Lowe VJ; Peller PJ; Wiseman GA
Nucl Med Commun; 2007 Nov; 28(11):834-41. PubMed ID: 17901765
[TBL] [Abstract][Full Text] [Related]
31. Combined use of 18 F-FDG PET and corticosteroid for diagnosis of deep-seated primary central nervous system lymphoma without histopathological confirmation.
Yamaguchi S; Hirata K; Kaneko S; Kobayashi H; Shiga T; Kobayashi K; Onimaru R; Shirato H; Tamaki N; Terasaka S; Houkin K
Acta Neurochir (Wien); 2015 Feb; 157(2):187-94. PubMed ID: 25488176
[TBL] [Abstract][Full Text] [Related]
32. Quantitative and Visual Characteristics of Primary Central Nervous System Lymphoma on
Liu D; Kong Z; Wang Y; Chen W; Wang Y; Chen W; Liu L; Dang Y; Ma W; Wang Y; Cheng X
Interdiscip Sci; 2019 Jun; 11(2):300-306. PubMed ID: 31264053
[TBL] [Abstract][Full Text] [Related]
33. A rare case of nonenhancing primary central nervous system lymphoma mimic multiple sclerosis.
Chen H; Dong H
Neurosciences (Riyadh); 2015 Oct; 20(4):380-4. PubMed ID: 26492120
[TBL] [Abstract][Full Text] [Related]
34. Differentiating between Primary Central Nervous System Lymphoma and Glioblastoma: The Diagnostic Value of Combining
Hatakeyama J; Ono T; Takahashi M; Oda M; Shimizu H
Neurol Med Chir (Tokyo); 2021 Jun; 61(6):367-375. PubMed ID: 33967177
[TBL] [Abstract][Full Text] [Related]
35. Utility of flouro-deoxy-glucose positron emission tomography/computed tomography in the diagnostic and staging evaluation of patients with primary CNS lymphoma.
Gupta M; Gupta T; Purandare N; Rangarajan V; Puranik A; Moiyadi A; Shetty P; Epari S; Sahay A; Mahajan A; Janu A; Bagal B; Menon H; Kannan S; Krishnatry R; Sastri GJ; Jalali R
CNS Oncol; 2019 Dec; 8(4):CNS46. PubMed ID: 31779471
[No Abstract] [Full Text] [Related]
36. 18F-FDG PET is an independent outcome predictor in primary central nervous system lymphoma.
Kasenda B; Haug V; Schorb E; Fritsch K; Finke J; Mix M; Hader C; Weber WA; Illerhaus G; Meyer PT
J Nucl Med; 2013 Feb; 54(2):184-91. PubMed ID: 23249539
[TBL] [Abstract][Full Text] [Related]
37. Evidence-based expert consensus on the management of primary central nervous system lymphoma in China.
Chen T; Liu Y; Wang Y; Chang Q; Wu J; Wang Z; Geng D; Yu JT; Li Y; Li XQ; Chen H; Zhuang D; Li J; Wang B; Jiang T; Lyu L; Song Y; Qiu X; Li W; Lin S; Zhang X; Lu D; Lei J; Chen Y; Mao Y
J Hematol Oncol; 2022 Sep; 15(1):136. PubMed ID: 36176002
[TBL] [Abstract][Full Text] [Related]
38. A False-Negative Case of Primary Central Nervous System Lymphoma on 11C-Methionine PET and Intense 18F-FDG Uptake.
García-Garzon JR; Villasboas-Rosciolesi D; Baquero M; Bassa P; Soler M; Riera E
Clin Nucl Med; 2016 Aug; 41(8):664-5. PubMed ID: 27187734
[TBL] [Abstract][Full Text] [Related]
39. The utility of body FDG PET in staging primary central nervous system lymphoma.
Mohile NA; Deangelis LM; Abrey LE
Neuro Oncol; 2008 Apr; 10(2):223-8. PubMed ID: 18287338
[TBL] [Abstract][Full Text] [Related]
40. Inflammatory brain lesions preceding primary central nervous system lymphoma: a case report and genetic analysis.
XiaoHong Z; Shuo Y; GeHong D; AnChao Y; Ce W; YunYun D; Can W; SiJie H; Feng C; WenBin L
Neurol Sci; 2023 May; 44(5):1555-1561. PubMed ID: 36599976
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
